Number 23

Are patients with multiple hepatic metastases from colorectal cancer candidates for surgery?

Impact Factor 1 March 2008 0

Results froma retrospective reviewof data from patients who under went resection for colorectal liver metastases indicate that partial hepatectomy for four or more hepatic colorectal cancer metastases is no longer contraindicated and is associated with [more]

... [ more ]

Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukaemia?

Impact Factor 1 March 2008 0

A study comparing the survival times of patients who received allogeneic transplantation for early stage CML with those of patients who received drug treatment showed that, with very few exceptions, drug treatment is the therapy [more]

... [ more ]

N E W S R O U N D

Senza categoria 1 March 2008 0

Selected reports edited by Hannah Brown Download full article

... [ more ]

It’s not just about surviving, it’s about getting your life back

Patient Voice 1 March 2008 0

Recent issues of CancerWorld have looked at the physical and psychosocial damage than can be inflicted by radiotherapy, chemotherapy and surgical cancer treatments. The final part of our series on Living with the consequences looks [more]

... [ more ]

To avoid the Big C, stay small

Focus 1 March 2008 0

Every day there are new stories in the tabloids about the latest link, sometimes tenuous, sometimes contradictory, between cancer and some aspect of lifestyle. If this is a recipe for confusion, then the antidote is [more]

... [ more ]

Diet and exercise: it’s time to act on the evidence

Editorial 1 March 2008 0

What if you could prescribe your patients a therapy that had proven powers to lift quality of life, boost psychological well-being, improve cardiorespiratory and physical fitness, and reduce fatigue? Download full article

... [ more ]

Giovanni Paganelli: nuclear medicine’s enthusiastic ambassador

Cover Story 1 March 2008 0

Radioisotopes can be used to locate tumours and to deliver targeted therapeutic radiation internally. Sounds ideal for cancer, yet nuclear medicine remains an underdeveloped field, held back by irrational fears of all things nuclear, false [more]

... [ more ]

Personalised cancer therapies: why we may never reach the promised land

Grandround 1 March 2008 0

New technologies offer wonderful possibilities for cancer patients. But the development of personalised therapies is being squeezed between the priorities of industry and a regulatory system that offers poor value for money. Is there a [more]

... [ more ]

Scientific integrity must always come first

Senza categoria 1 March 2008 0

Challenging medical orthodoxies is essential in the interests of good science and improving patient care. All top-class doctors do it, but few enjoy the battle as much as breast cancer specialist Michael Baum. He has [more]

... [ more ]